Searchable abstracts of presentations at key conferences in endocrinology

ea0081p522 | Adrenal and Cardiovascular Endocrinology | ECE2022

Gastric monomorphic epitheliotropic intestinal T-cell lymphoma with bilateral adrenal metastases

Kaliakatsou Eirini , Markou Athina , Papanastasiou Labrini , Giagourta Irini , Kalantzi Athanasia , Dimitriadi Anastasia , Lenos Michael , Kounadi Theodora , Fountas Athanasios

Introduction: Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL), formerly known as type II enteropathy-associated T-cell lymphoma, is a rare and aggressive subtype of lymphoma of the gastrointestinal track typically noted in Asian or Hispanic populations. Adrenal involvement as part of MEITL is extremely rare. Herein we present a patient of Greek origin with MEITL and bilateral adrenal metastases.Case Presentation: A 74-year-old man presente...

ea0081ep699 | Pituitary and Neuroendocrinology | ECE2022

Pituitary adenomas characteristics in patients with multiple endocrine neoplasia type 1, its phenocopies and sporadic acromegaly

Trukhina Diana , Mamedova Elizaveta , Lapshina Anastasia , Nikitin Alexey , Koshkin Philipp , Azizyan Vilen , Grigoriev Andrey , Belaya Zhanna , Melnichenko Galina

Multiple endocrine neoplasia type 1(MEN1) is a hereditary condition caused by mutations in the MEN1 gene, which encodes menin protein. The syndrome predisposes to the development of tumors in both endocrine and non-endocrine systems. In patients with MEN1, pituitary adenomas (PA) occur in approximately 40% of all cases. If patient has MEN1 phenotype with no mutations in MEN1 gene, the condition is regarded as a phenocopy. The reason of several endocrine MEN1-...

ea0086p247 | Neuroendocrinology and Pituitary | SFEBES2022

Surgical management of prolactinomas in patients with dopamine agonist-associated impulse control disorders or who are deemed at ‘high risk’

T. C. Yu Arthur , Wernig Florian , Meeran Karim , Martin Niamh , Mendoza Nigel , Nair Ramesh , Jones Brynmor , Gontsarova Anastasia , Behary Preeshila

Introduction: Prolactinomas are the commonest type of secretory pituitary tumours. In current practice, dopamine agonists (DA) remain the mainstay treatment. However, treating physicians are increasingly aware of DA-associated impulse control disorders (ICD) in their patients. We describe 4 individuals with prolactinomas, who either developed ICD on DA or deemed at ‘high risk’, successfully managed surgically with preservation of pituitary function. All decisions for...

ea0091p37 | Poster Presentations | SFEEU2023

Craniopharyngioma: A Comprehensive Overview of a Challenging Pituitary Mass

Mcgown Patrick , Narula Kavita , Nair Ramesh , Gontsarova Anastasia , Jaunmuktane Zane , Ferguson Mark , Mendoza Nigel , Martin Niamh , Meeran Karim , Mehta Sanjeev

Case history : A 44-year-old female presented with 6-week history of gradual deterioration in her left vision associated with eye pain. She saw an ophthalmologist who noted that she had reduced visual acuity (6/24) and colour vision (Ishihara colour vision score 3/15) in her left eye with left relative afferent pupillary defect (RAPD). It was thought that she may have a left retrobulbar neuritis so she was advised to attend A&E for an urgent neurology assessment. On examin...

ea0065p218 | Metabolism and Obesity | SFEBES2019

Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) prevents cytokine-mediated beta cell dysfunction

Egbase Daniel , Sayers Sophie , Evans Elizabeth , Butterworth Sam , Greally Joshua , Bewick Gavin , Tsakmaki Anastasia , Persaud Shanta , Caton Paul

Intracellular nicotinamide phosphoribosyltransferase (NAMPT) is the rate-limiting enzyme in the NAD salvage pathway. Abnormally elevated NAMPT can promote autoimmune and inflammatory processes. Many of these processes are key to type 1 diabetes (T1D) pathogenesis. Whilst NAMPT has been examined in other inflammatory diseases, the role of NAMPT in T1D remains unclear. To investigate the role of NAMPT in T1D, we used small molecule NAMPT modulators to determine the role of abnor...

ea0065p377 | Reproductive Endocrinology and Biology | SFEBES2019

A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal women

Dimakopoulou Anastasia , Jayasena Channa N , Alkaabi Fatima M , Liebers Curtis S , Handley Thomas , Franks Stephen , Dhillo Waljit S

Introduction: Over half of postmenopausal women suffer symptoms which can sometimes be non-responsive to hormone replacement therapy (HRT). Testosterone is implicated in regulating urogenital and sexual function in women. However, using testosterone therapy in postmenopausal women remains highly controversial, principally due to the lack of syndromic relationship between serum testosterone levels and onset of sexual dysfunction during menopause. Clinical practice is therefore ...

ea0067o26 | Oral Presentations | EYES2019

Associations between FSH levels and indices of regional and total obesity in women after menopause

Armeni Eleni , Paschou Stavroula A , Augoulea Areti , Stergiotis Stefanos , Chatzivasiliou Panagiota , Rizos Dimitrios , Kaparos George , Panoulis Konstantinos , Palaiologou Anastasia , Lambrinoudaki Irene

Objective: Recent evidence reports a controversial extra-gonadal role of follicle stimulating hormone (FSH). Conflicting data support that the association between FSH and obesity might be maintained by a direct or even indirect effect to the adipose tissue. The aim of this study was to evaluate the associations between FSH concentrations and various obesity indices in women after menopause.Methods: This cross-sectional study included 420 postmenopausal w...

ea0063p647 | Interdisciplinary Endocrinology 1 | ECE2019

5-Beta-reductase (AKR1D1) deletion leads to increased insulin sensitivity in mature male mice

Arvaniti Anastasia , Harris Shelley , Nikolaou Nikolaos , Hazlehurst Jonathan , Moolla Ahmad , Dempster Niall , Cox Roger , Gathercole Laura , Tomlinson Jeremy

Bile acids (BA) are potent steroid hormones that mediate a variety of metabolic effects. They play a pivotal role in cholesterol catabolism, intestine nutrient absorption, and regulate lipid, glucose and energy metabolism. 5-Beta-Reductase (AKR1D1) is a key enzyme in the BA synthesis pathway, required for cholesterol metabolism into bile acids. We generated a novel global AKR1D1 knockout (KO) mouse which, as expected, has decreased total serum and hepatic BAs and altered BA co...

ea0063p1212 | Thyroid 3 | ECE2019

Hypothyroidism and lymphoma in a patient with systemic sclerosis

Samaras Charilaos , Siarkos Evangelos , Athanassiou Lambros , Fasfali Dimitra , Kourentzi Kalliopi , Fabri Anastasia , Potamousi Paraskevi , Kostoglou-Athanassiou Ifigenia

Introduction: Patients with systemic sclerosis may develop cancer. The development of malignant hematological diseases has also been described in patients with systemic sclerosis. These patients may also be prone to the development of lymphoma, in most cases a B-cell lymphoma.Aim: The aim was to describe the case of a patient with systemic sclerosis who had a non-Hodgkin’s lymphoma and developed primary hypothyroidism.Case rep...

ea0063ep28 | Calcium and Bone | ECE2019

The impact of gastrointestinal diseases on bone quality: description of two cases

Kostoglou-Athanassiou Ifigenia , Athanassiou Lambros , Fasfali Dimitra , Fabri Anastasia , Giagtzoglou Ioannis , Siarkos Evangelos , Samaras Charilaos , Potamousi Paraskevi , Athanassiou Panagiotis

Introduction: Diseases of the gastrointestinal tract may have on effect on bone quality manifesting either as osteomalacia or as osteoporosis. Gastritis may have an effect on bone as it requires long term treatment with proton pump inhibitors. Gastrointestinal neoplasms may be accompanied by nutrient malabsorption. These diseases may also be related with vitamin D deficiency.Aim: The aim was to describe two cases of gastrointestinal diseases, namely chro...